American Assets Trust (AAT) stock prices updated...
 

American Assets Trust stock price

American Assets Trust latest news:


  • 12/13/2017 10:01:32

    EMERGING MARKETS-LatAm currencies firm on bets of slower U.S. rate hikes

    By Bruno Federowski BRASILIA, Dec 13 (Reuters) - Latin American currencies strengthened on Wednesday, a day after U.S. President Donald Trump's Republicans suffered defeat in a special election in Alabama, imposing a possible hurdle to his policy agenda. Expectations that Trump's efforts to cut taxes and boost infrastructure investments could boost U.S. economic growth and speed up inflation have weighed on investor demand for emerging market assets in recent months. Quickening i

  • 11/30/2017 13:39:43

    Time Inc. sells 'Sunset' lifestyle brand to private equity firm

    Time Inc. said on Thursday that it's selling its "Sunset" lifestyle brand to Los Angeles-based private equity firm Regent L.P. "Sunset," a monthly print publication, covers travel, food, wine and home and garden as a lifestyle magazine of the American West. The sale of "Sunset" comes after news magazine publisher Meredith Corp. has proposed a $2.8 billion acquisition of Time Inc. The "Time" and "Sports Illustrated" publisher has been struggling to make up for its declining print business. Time has said it plans to target more than $400 million in cost savings as it sells off assets and focuses on its core brands. Shares of Time are up nearly 4% in the year to date, while the S&P 500 index is up more than 18% and the Dow Jones Industrial Average is up more than 21%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/07/2017 05:38:39

    Teva's stock, bonds fall after credit rating slashed to junk at Fitch

    Shares of Teva Pharmaceutical Industries Ltd. sank 3.6% in premarket trade Tuesday, after the Israel-based generic drug maker's credit rating was cut by two notches into "junk" territory by Fitch Ratings. Teva's most active bonds, the 3.150% notes that mature in October of 2026, fell about 3 points to 83 cents on the dollar, sending its yield up to 5.466%. The spread widened by 27 basis points to 315 basis points over comparable Treasuries. The credit rating agency said the cut in the rating, down to BB from BBB-, reflects concerns over "significant operational stress" at a time when it needs to reduce debt. "Pricing pressure in Teva's North American generics segment and erosion of sales of Copaxone will continue to weigh on free cash flow in the near term, requiring the company to continue to sell assets or find external capital resources to meed debt obligations in 2018 and 2019 and beyond," Fitch said in a statement. The rating outlook is negative. Teva's stock has plunged 66% year to date through Monday, while the SPDR S&P Pharmaceuticals ETF has gained 5.4% and the S&P 500 has climbed 16%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    American Axle & Manufacturing HoldingsAXL | American Campus Communities IncACC | American Eagle OutfittersAEO | American Electric Power CompanyAEP | American Equity Investment Life Holding CompanyAEL | American Express CompanyAXP | American Financial GroupAFA | American Financial GroupAFG | American Financial GroupAFGE | American Financial GroupAFQ |